Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Metadoxine + garlic oil** is a combination therapy comprising metadoxine (a salt formed between pyridoxine and pyrrolidone carboxylate) and garlic oil. Metadoxine accelerates the elimination of alcohol and acetaldehyde, inhibits alcohol-induced free radical toxicity, reduces hepatic inflammation (including inducible nitric oxide synthase/iNOS levels), and helps to restore key hepatic enzymes affected in fatty liver disease. Garlic oil exhibits cytochrome P450 2E1 (CYP2E1) inhibition, further reducing oxidative stress and hepatocyte injury due to alcohol. When administered together, these agents act synergistically to reduce hepatic steatosis, restore activities of AMP-activated protein kinase (AMPK) and acetyl-CoA carboxylase (ACC), restore fatty acid synthase (FAS) expression, and improve liver function more effectively than when used alone. The primary research and development focus for this combination is the prevention and treatment of alcohol-induced fatty liver and steatohepatitis, with the combination also being considered for restoring and improving liver function after alcohol damage[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on metadoxine + garlic oil.